Thomas Kim - 15 Jun 2022 Form 4 Insider Report for Enfusion, Inc.

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: N/A
Reported as of: 15 Jun 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 17 Jun 2022, 21:46:38 UTC
Prior SEC filing: 21 Oct 2021
Source filing: View source filing
Reporting owner signature: /s/ Blake Nielsen, as Attorney-in-Fact

Filing notes and source

Key filing fact

Thomas Kim filed Form 4 for Enfusion, Inc. on 17 Jun 2022.

Key facts

This page summarizes Thomas Kim's Form 4 filing for Enfusion, Inc..
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 17 Jun 2022, 21:46.

Change

Previous filing in this sequence was filed on 21 Oct 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ENFN transaction

Class A Common Stock

Award

Transaction value: $0
Shares: +20,284
Change %: +2.4%
Price: $0.000000
Shares after: 865,872
Date: 15 Jun 2022
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ENFN transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +32,000
Change %
Price: $0.000000
Shares after: 32,000
Date: 15 Jun 2022
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 32,000
Exercise price: $9.86
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Consist of restricted stock units ("RSUs") awarded pursuant to the Enfusion, Inc. 2021 Stock Option and Incentive Plan (the "Plan"). The restricted stock units will vest in full as follows: 6,762, 6,761 and 6,761 restricted stock units will vest on June 15, 2023, June 15, 2024 and June 15, 2025, respectively.

Footnote F2

These options were granted under the Plan and shall become exercisable as follows: 10,667, 10,667 and 10,666 on June 15, 2023, June 15, 2024 and June 15, 2025, respectively.